Financial Data and Key Metrics Changes - Revenue for Q2 2025 was $263 million, compared to $267 million in Q2 2024, reflecting a decline of $4 million or 1% year-over-year [8][24] - Gross profit decreased by $7 million or 12% year-over-year, with a gross profit percentage of 19% in Q2 2025 compared to 22% in Q2 2024 [10][25] - The company reported a net loss of $26 million for Q2 2025, compared to net income of $26 million in the prior year quarter, a decrease of $52 million [26] - Operational EBITDA for Q2 2025 was $9 million, down from $12 million in Q2 2024, a decline of $3 million [27] Business Line Data and Key Metrics Changes - The Advanced Materials and Chemicals (AMC) business continued to show revenue growth, indicating successful investments in this area [9][24] - The commercial print business remains the largest segment, with ongoing improvements in efficiency and product acceptance [13] Market Data and Key Metrics Changes - Year-to-date tariffs did not have a material impact on the business, and the company supports tariffs that benefit U.S. manufacturers [12] - The company continues to focus on U.S. manufacturing, with key production facilities located in Rochester, New York [11] Company Strategy and Development Direction - The company is focused on deleveraging its business and strengthening its balance sheet while investing in growth areas [7][35] - Kodak's CGMP pharmaceutical manufacturing facility is now registered with the FDA, allowing it to manufacture and sell regulated pharmaceutical products [15][36] - The company plans to use excess assets from the pension plan termination to pay down debt and reduce interest costs [20][37] Management's Comments on Operating Environment and Future Outlook - Management acknowledged the uncertainty in the global business environment, including tariffs and logistics challenges, but remains committed to executing the long-term plan [7][35] - The company expects to continue investing in profitable growth businesses despite the challenges [36] Other Important Information - The termination and reversion process for the U.S. Kodak Retirement Income Plan (CRIP) is proceeding as planned, with an estimated $500 million in pension assets expected to revert to the company [18][20] - The Series C preferred stock was exchanged for common stock, eliminating the outstanding amount of $100 million in Series C preferred stock [19] Summary of Q&A Session - There was no formal Q&A session during the call, but the management team encouraged follow-up questions through the Investor Relations team [5]